Skip to main content
. 2015 Oct 15;1(1):e1–e15. doi: 10.1055/s-0035-1565246

Table 1. Common photosensitizers in use for clinical PDT in oncology (manufacturers and web sites listed in Appendix 1).

Family Name Alternative/Abbreviation Activation light (nm) Remark
Porphyrin Hematoporphyrin derivative HpD 630 Precursor of Photofrin
Porphyrin Photofrin Porfimer sodium 630–635 Multipurpose
Porphyrin (prodrug) Levulan 5-ALA 630 Topical/skin
Porphyrin (prodrug) Metvix Methyl-ALA 630 Mainly skin
Porphyrin (prodrug) Visudyne Verteporfin 619 Experimental for oncology
Porphyrin (prodrug) Hexaminolevulinate hydrochloride HALA Fluorescence cystoscopy
Texaphyrin Lutexaphyrin/lutetium texaphyrin Lutex, Optrin 730 Experimental, clinical
Chlorin Foscan mTHPC 525–660a Head and neck, others/variable
Chlorin Talaporfin
Chlorin NPe6 Mono-L-aspartyl chlorin 6 664 Lung cancer
Chlorin Photochlor HPPH 665–680
Bacteriochlorin TOOKAD Metal complex bacteriochlorin 760 Vascular targeted, prostate
Dye Photosens Phthalocyanine 650–850 Various

Abbreviations: ALA, aminolevulinic acid; mTHPC, meso-tetraphenyl chlorine; PDT, photodynamic therapy; TOOKAD, Pd-bacteriopheophorbide.

a

Esophagus.